跳转至内容
Merck
所有图片(2)

主要文件

查看所有文档

850446P

Avanti

14:0-18:0 PC

1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine, powder

别名:

1-十四烷酰基-2-十八烷酰基-sn-甘油-3-磷酰胆碱；MSPC；PC(14:0/18:0)

登录查看公司和协议定价
所有图片(2)

About This Item

经验公式（希尔记法）:
C40H80NO8P
CAS号:
76343-22-1
分子量:
734.04
MDL號碼:
MFCD00674323
分類程式碼代碼:
51191904
NACRES:
NA.25
价格与库存信息目前不能提供

化驗

>99% (TLC)

形狀

powder

包裝

pkg of 1 × 200 mg (850446P-200mg)
pkg of 1 × 25 mg (850446P-25mg)

製造商／商標名

Avanti Research™ - A Croda Brand 850446P

脂質類型

phospholipids
cardiolipins

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCC)=O)=O

InChI

1S/C40H80NO8P/c1-6-8-10-12-14-16-18-19-20-21-23-25-27-29-31-33-40(43)49-38(37-48-50(44,45)47-35-34-41(3,4)5)36-46-39(42)32-30-28-26-24-22-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1

InChI 密鑰

TYAQXZHDAGZOEO-KXQOOQHDSA-N

相关类别

一般說明

磷脂酰胆碱（PC）是结肠′粘膜层最重要的成分之一。[1]14:0-18:0 PC（1-肉豆蔻酰基-2-硬脂酰基-sn-甘油-3-磷酸胆碱）是具有长烷基侧链的不对称脂质。[2]

應用

14:0-18:0 PC（1-肉豆蔻酰基-2-硬脂酰基-sn-甘油-3-磷酸胆碱）可用于：
  • 脂质双层，采用差示扫描量热法（DSC）研究其与d-赤型-N-棕榈酰基-鞘磷脂（16:0-SM）的混溶性，[3]
  • 作为脂质体中的不对称脂质成分，研究双层面积和脂质几何形状的影响，并作为脂质体增溶剂[2]
  • 制备用于溶栓研究的低温敏感脂质体[4]

生化／生理作用

磷脂酰胆碱（PC）通过充当表面活性剂在粘液中形成疏水表面，从而抑制细菌的渗透。[1]

包裝

5 mL棕色玻璃螺旋盖小瓶（850446P-200mg）
5 mL棕色玻璃螺旋盖小瓶（850446P-25mg）

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

也與該產品經常一起購買

产品编号
说明
价格

儲存類別代碼

11 - Combustible Solids

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Inflammatory Bowel Disease
Integrative Medicine, 501-516 (2018)
Vishal Saxena et al.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 31(1), 67-73 (2015-03-15)
Clinical efficacy of thrombolytic drugs is limited by lack of specific delivery and requires large therapeutic doses which increase toxicity. Encapsulating these drugs in temperature-sensitive liposomes and applying hyperthermia to deliver thrombolytic agents locally to thrombus might theoretically favourably alter
M Habib Ali et al.
International journal of pharmaceutics, 453(1), 225-232 (2012-07-07)
Liposomes are well recognised for their ability to improve the delivery of a range of drugs. More commonly they are applied for the delivery of water-soluble drugs, but given their structural attributes, they can also be employed as solubilising agents
Van Du Nguyen et al.
ACS applied materials & interfaces, 12(9), 10130-10141 (2020-02-12)
Although great efforts have been undertaken to develop a nanoparticle-based drug delivery system (DDS) for the treatment of solid tumors, the therapeutic outcomes are still limited. Immune cells, which possess an intrinsic ability to phagocytose nanoparticles and are recruited by
Bohdana Térová et al.
Biochimica et biophysica acta, 1667(2), 182-189 (2004-12-08)
In this study we have used differential scanning calorimetry (DSC) to study the miscibility of different saturated phosphatidylcholines (PCs) with D-erythro-N-palmitoyl-sphingomyelin (16:0-SM). Information about the miscibility was obtained by observing the thermotropic phase behavior of binary mixtures of saturated PCs
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门